Dash Bio

📍 Boston, United States🗓 Founded 2024👥 29 employees💰 Last funded Jun 2025
Biotechnology Research🌐 dash.bio
Website LinkedIn
At Dash Bio, were revolutionizing bioanalysis to expedite drug development. By leveraging robotics and modern software, we deliver higher-quality assays with turnaround times up to 10x faster than the industry average, scaling seamlessly from preclinical through late-stage clinical studies. While drug discovery has been revolutionized with AI and breakthrough modalities, the development phase remains bogged down by manual, labor-intensive processes. Were changing that narrative. Our tech-first products automate critical steps, reducing costs and time to market while improving quality of results. Meet Our Leadership Team: Dave Johnson, CEO: Former Chief Data and AI Officer at Moderna. Ander Tallett, COO: Led Enterprise Systems at Moderna and Resilience. Ely Porter, CSO: Co-founder and CTO of Rootpath. Together, were crafting a future where bioanalysis is intuitive, data flows effortlessly, and drugs reach the market faster than ever before. Join us on this journey. Learn more at dash.bio
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2024
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
France
1
United States
1
United Kingdom
1
Investor activity2024–2025 · investors recorded per year
2024220251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Dash Bio?
Dash Bio has 3 investors on record on gritt.io, including 3 early-stage backers.
When did Dash Bio last raise funding?
The most recent investment in Dash Bio recorded on gritt.io was in June 2025.
When was Dash Bio founded?
Dash Bio was founded in 2024.
What industry is Dash Bio in?
Dash Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Dash Bio based?
Dash Bio is headquartered in Boston, United States.